Hong Kong Genome Centre board members reappointed and new members named
Hong Kong's medical health minister reappointed the chairman and vice-chairman of the Hong Kong Genome Centre and named six reappointed and seven new non-official board members. The centre runs the Hong Kong Genome Project, which met its first-phase target of recruiting 50,000 participants ahead of
The Secretary for Health of the Hong Kong Special Administrative Region Government has reappointed Choy Chung-wo and Professor Joseph Leung Yin-sing as Chairman (until 26 July 2027) and Vice-Chairman (until 26 July 2028) of the Hong Kong Genome Centre, according to a government press release on 13 November 2026.
The Secretary also reappointed six non-official directors and appointed seven new non-official directors. The new directors are Professor Chiu Wai-yan, Professor Ho Wing-kei, Hung Suk-fan, Lai Ka-wai, Professor Lee King-sun, Dr Ma Pui-yan and Yip Ka-ming. All non-official directors serve until 4 November 2028.
The Hong Kong Genome Centre is a wholly government-owned private limited company responsible for implementing the Hong Kong Genome Project. With support from the Health Bureau, the centre promotes the development of genomic medicine in Hong Kong and works closely with the Department of Health, the Hospital Authority, local university medical schools and other stakeholders to accelerate the integration of genomic medicine into clinical practice, advance scientific research, train professionals and raise public awareness of genomics.
Secretary for Health Professor Lo Chung-mau said: “I am pleased that the Hong Kong Genome Project reached its first-phase target of recruiting 50,000 participants ahead of schedule last year. By analysing whole-genome sequencing results, clinical healthcare workers can make more accurate diagnoses and provide participants with more suitable treatment and prevention plans. The project also helps establish a database combining genetic and clinical data in Hong Kong, enabling healthcare workers and researchers to understand the causes of different diseases and drive the development of more effective screening, diagnosis and treatment methods.”
“I believe that under the outstanding leadership of Choy Chung-wo and Professor Leung Yin-sing, and with the strong support of the new board members, the Hong Kong Genome Centre will continue to advance the steady development of genomic medicine, benefit more citizens and help develop Hong Kong into an international medical innovation hub,” Lo added.
Lo expressed heartfelt thanks to the outgoing directors – Chan Chin-ching, Cheung Ying-hin, Dr Leung Sui-on, Dr Lau Fong-kwan, Professor Lo Yat-ming, Pang Hung-cheong, Professor Wong Chi-kei, Dr Wong Lap-ji and Professor Yiu Ming-sing – for their full support and valuable contributions to the centre's work during their tenures.
